Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir ®) on 2010-2011 seasonal influenza viruses: An open phase IV study

International Journal of Infectious Diseases

Volumn 16, Issue 4, 2012, Pages

  Ceyhan, Mehmet ^a   Karadag Oncel, Eda ^a   Badur, Selim ^b   Ciblak, Meral Akcay ^b   Alhan, Emre ^c   Celik, Umit Sizmaz ^c   Kurugol, Zafer ^d   Saz, Eylem Ulas ^d   Ozsurekci, Yasemin ^a   Celik, Melda ^a   Parlakay, Aslinur Ozkaya ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c CUKUROVA UNIVERSITY   (Turkey)

^d EGE UNIVERSITY   (Turkey)

Author keywords

Children; Influenza; Oseltamivir; Symptom duration

Indexed keywords

ENFLUVIR; OSELTAMIVIR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BIOEQUIVALENCE; CHILD; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA B; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE CONGESTION; NOSE SMEAR; OPEN STUDY; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINORRHEA; SCHOOL CHILD; SEASONAL INFLUENZA; VIRUS DETECTION; VIRUS STRAIN;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; OSELTAMIVIR; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 84858282210     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.12.008     Document Type: Article

References (38)

1. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008, 57:1-60.
2. Ruf B.R., Szucs T. Reducing the burden of influenza-associated complications with antiviral therapy. Infection 2009, 37:186-196.
3. Ansaldi F., Icardi G., Gasparini R., Campello C., Puzelli S., Bella A., et al. New A/H3N2 influenza variant: a small genetic evaluation but a heavy burden on the Italian population during the 2004-2005 season. J Clin Microbiol 2005, 43:3027-3029.
4. Ng T.P., Pwee K.H., Niti M., Goh L.G. Influenza in Singapore: assessing the burden of illness in the community. Ann Acad Med Singapore 2002, 31:182-188.
5. Belongia E.A., Irving S.A., Waring S.C., Coleman L.A., Meece J.K., Vandermause M., et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010, 304:1091-1098.
6. Rothberg M.B., Haessler S.D. Complications of seasonal and pandemic influenza. Crit Care Med 2010, 38:91-97.
7. Lee N., Chan P.K., Wong C.K., Wong K.T., Choi K.W., Joynt G.M. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A (H1N1) virus pneumonia. Antivir Ther 2011, 16:237-247.
8. McGeer A., Gren K.A., Plevneshi A., Shigayeva A., Siddiqi N., Raboud J., et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45:1568-1575.
9. Hanshaoworakul W., Simmerman J.M., Narueponjirakul U., Sanasuttipun W., Shinde V., Kaewchana S., et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009, 4:6051.
10. Call S.A., Vollenweider M.A., Hornung C.A., Simel D.L., McKinney W.P. Does this patient have influenza?. JAMA 2005, 293:987-997.
11. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza associated deaths among children in the United States, 2003-2004. N Engl J Med 2005, 353:2559-2667.
12. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342:232-239.
13. Ampofo K., Gesteland P.H., Bender J., Mills M., Daly J., Samore M., et al. Epidemiology, complications, and cost of hospitalization in children with laboratory confirmed influenza infection. Pediatrics 2006, 118:2409-2417.
14. Principi N., Esposito S., Marchisio P., Gasparini R., Crovari P. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003, 22:207-210.
15. Tsolia M.N., Logotheti I., Papadopoulos N.G., Mavrikou M., Spyridis N.P., Drossatou P., et al. Impact of influenza infection in healthy children examined as outpatients and their families. Vaccine 2006, 24:5970-5976.
16. Cowling B.J., Chan K.H., Fang V.J., Lau L.L., So H.C., Fung R.O., et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010, 362:2175-2184.
17. Babcock H.M., Merz L.R., Fraser V.J. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2006, 27:266-270.
18. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005, 353:1363-1373.
19. Heinonen S., Silvennoinen H., Lehtinen P., Vainionpää R., Vahlberg T., Ziegler T., et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis 2010, 51:887-894.
20. Whitley R.J., Hayden F.G., Reisinger K.S., Young N., Dutkowski R., Ipe D., et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001, 20:127-133.
21. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Atlanta, GA: CDC; 2009. Available at: (accessed December 7, 2009). http://www.cdc.gov/h1n1flu/recommendations.htm.
22. Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J Virol 2006, 80:7590-7599.
23. Lee N., Chan P.K., Hui D.S., Rainer T.H., Wong E., Choi K.W., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009, 200:492-500.
24. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 2006, 355:31-40.
25. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785.
26. Aoki F.Y., Macleod M.D., Paggiaro P., Carewicz O., El Sawy A., Wat C., et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003, 51:123-129.
27. Peltola V., Reunanen T., Ziegler T., Silvennoinen H., Heikkinen T. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005, 41:1198-1200.
28. Freidman M.J., Attia M.W. Clinical predictors of influenza in children. Arch Pediatr Adolesc Med 2004, 158:391-394.
29. Heikkinen T., Silvennoinen H., Peltola V., Ziegler T., Vainionpaa R., Vuorinen T., et al. Burden of influenza in children in the community. J Infect Dis 2004, 190:1369-1373.
30. Heikkinen T., Thint M., Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999, 340:260-264.
31. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008, 6:114-124.
32. Fujimoto S., Kobayashi M., Uemura O., Iwasa M., Ando T., Katoh T., et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet 1998, 352:873-875.
33. Chiu S.S., Tse C.Y., Lau Y.L., Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics 2001, 108:63.
34. Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003, 28:225-232.
35. McCall S., Vilensky J.A., Gilman S., Taubenberger J.K. The relationship between encephalitis lethargica and influenza: a critical analysis. J Neurovirol 2008, 14:177-185.
36. Nicholson K.G. Clinical features of influenza. Semin Respir Infect 1992, 7:26-37.
37. Centers for Disease Control and Prevention. Update: influenza activity-United States, October 3, 2010-February 5, 2011. MMWR Morb Mortal Wkly Rep 2011;60:175-81.
38. Gordon A., Saborío S., Videa E., López R., Kuan G., Balmaseda A., et al. Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis 2010, 50:1462-1467.